Latest filing published 21 Jan 2015 for EASTGATE ACQUISITIONS CORP, €42k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anna E. Gluskin: trading record in brief
Anna E. Gluskin has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Eastgate Acquisitions Corp and Generex Biotechnology Corp. In total, 5 filings cover trades dated from 17 August 2007 to 5 January 2015.
On the market, this insider has only ever bought: 4 purchases, €290k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. 2015 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €65k.
The newest entry dates from 21 January 2015: an open-market purchase of €42k, in Eastgate Acquisitions Corp. Typically, a trade is published a median of 13 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Anna E. Gluskin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,243,750 shares@ US$0.04Common StockSEC:0001125857-15-000001:0Canonical exit: 5 Apr 2015 (T+90)
- 480,000 shares@ US$0.25Common StockSEC:0001125857-14-000006:0Canonical exit: 7 Sept 2014 (T+90)
- 864,000 shares@ US$0.25Common StockSEC:0001125857-14-000001:0Canonical exit: 19 Jun 2014 (T+90)
- 10,000 shares@ US$0.51Common StockSEC:0001144204-09-059725:0Canonical exit: 14 Feb 2010 (T+90)
- 200,000 shares0Common StockSEC:0001144204-07-045651:0
5 of 5 declarations